Bastide Le Confort Médical SA (0IP1.L)
EUR 23.85
(-0.63%)
EUR 23.85
(-0.63%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | 44.22 Million EUR | 3.27% |
| 2023 | 42.82 Million EUR | 9.98% |
| 2022 | 38.93 Million EUR | 3.82% |
| 2021 | 37.5 Million EUR | 11.31% |
| 2020 | 33.69 Million EUR | 22.98% |
| 2019 | 27.39 Million EUR | 41.91% |
| 2018 | 19.3 Million EUR | 62.21% |
| 2017 | 11.9 Million EUR | -13.74% |
| 2016 | 13.79 Million EUR | 5.43% |
| 2015 | 13.08 Million EUR | 18.65% |
| 2014 | 11.02 Million EUR | 27.87% |
| 2013 | 8.62 Million EUR | 12.79% |
| 2012 | 7.64 Million EUR | 16.68% |
| 2011 | 6.55 Million EUR | 5.51% |
| 2010 | 6.21 Million EUR | 36.65% |
| 2009 | 4.54 Million EUR | -53.87% |
| 2008 | 9.85 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 20.64 Million EUR | 0.0% |
| 2024 Q4 | 22.17 Million EUR | 0.0% |
| 2023 Q2 | 20.14 Million EUR | 0.0% |
| 2023 FY | 42.82 Million EUR | 9.98% |
| 2023 Q4 | 22.67 Million EUR | 0.0% |
| 2022 FY | 38.93 Million EUR | 3.82% |
| 2022 Q4 | 19.94 Million EUR | 0.0% |
| 2022 Q2 | 18.98 Million EUR | 0.0% |
| 2021 Q4 | 20.56 Million EUR | 0.0% |
| 2021 Q2 | 16.94 Million EUR | 0.0% |
| 2021 FY | 37.5 Million EUR | 11.31% |
| 2020 Q2 | 15.71 Million EUR | 0.0% |
| 2020 Q4 | 17.97 Million EUR | 0.0% |
| 2020 FY | 33.69 Million EUR | 22.98% |
| 2019 Q4 | 15.14 Million EUR | 0.0% |
| 2019 FY | 27.39 Million EUR | 41.91% |
| 2019 Q2 | 12.25 Million EUR | 0.0% |
| 2018 FY | 19.3 Million EUR | 62.21% |
| 2018 Q4 | 9.87 Million EUR | 0.0% |
| 2018 Q2 | 9.42 Million EUR | 0.0% |
| 2017 Q2 | 8.72 Million EUR | 0.0% |
| 2017 FY | 11.9 Million EUR | -13.74% |
| 2017 Q4 | 3.17 Million EUR | 0.0% |
| 2016 FY | 13.79 Million EUR | 5.43% |
| 2016 Q2 | 6.95 Million EUR | 0.0% |
| 2016 Q4 | 6.84 Million EUR | 0.0% |
| 2015 FY | 13.08 Million EUR | 18.65% |
| 2015 Q2 | 7.09 Million EUR | 0.0% |
| 2015 Q4 | 5.99 Million EUR | 0.0% |
| 2014 FY | 11.02 Million EUR | 27.87% |
| 2014 Q4 | 5.53 Million EUR | 0.0% |
| 2014 Q2 | 5.49 Million EUR | 0.0% |
| 2013 Q4 | 4.21 Million EUR | 0.0% |
| 2013 Q2 | 4.41 Million EUR | 0.0% |
| 2013 FY | 8.62 Million EUR | 12.79% |
| 2012 Q4 | 1.91 Million EUR | 0.0% |
| 2012 Q3 | 1.91 Million EUR | 0.0% |
| 2012 FY | 7.64 Million EUR | 16.68% |
| 2012 Q2 | 1.91 Million EUR | 16.66% |
| 2012 Q1 | 1.63 Million EUR | 0.0% |
| 2011 Q1 | 1.55 Million EUR | 0.0% |
| 2011 Q2 | 1.63 Million EUR | 5.51% |
| 2011 Q3 | 1.63 Million EUR | 0.0% |
| 2011 Q4 | 1.63 Million EUR | 0.0% |
| 2011 FY | 6.55 Million EUR | 5.51% |
| 2010 Q3 | 1.55 Million EUR | 0.0% |
| 2010 Q4 | 1.55 Million EUR | 0.0% |
| 2010 Q2 | 1.55 Million EUR | 36.65% |
| 2010 FY | 6.21 Million EUR | 36.65% |
| 2010 Q1 | 1.13 Million EUR | 0.0% |
| 2009 Q4 | 1.13 Million EUR | 0.0% |
| 2009 Q3 | 1.13 Million EUR | 0.0% |
| 2009 Q2 | 1.13 Million EUR | -53.87% |
| 2009 Q1 | 2.46 Million EUR | 0.0% |
| 2009 FY | 4.54 Million EUR | -53.87% |
| 2008 FY | 9.85 Million EUR | 0.0% |
| 2008 Q4 | 2.46 Million EUR | 0.0% |
| 2008 Q3 | 2.46 Million EUR | 0.0% |
| 2008 Q2 | 2.46 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Cegedim SA | 19.98 Million EUR | -121.298% |
| Guerbet SA | 38.67 Million EUR | -14.354% |
| Nexus AG | 24.76 Million EUR | -78.559% |
| Revenio Group Oyj | 26.34 Million EUR | -67.87% |
| Drägerwerk AG & Co. KGaA | 171.18 Million EUR | 74.167% |
| Sartorius Aktiengesellschaft | 541 Million EUR | 91.826% |
| LNA Santé SA | 62.98 Million EUR | 29.785% |
| Siemens Healthineers AG | 2.86 Billion EUR | 98.459% |
| Medios AG | 31.37 Million EUR | -40.965% |
| Equasens Société anonyme | 55.2 Million EUR | 19.899% |
| Stratec SE | 22.88 Million EUR | -93.21% |